[Primary hyperparathyroidism. Mechanisms of hypercalcemia].

Area of Science:

• Endocrinology
• Metabolic Bone Disease

Background:

• Primary hyperparathyroidism is characterized by hypercalcemia resulting from excessive parathormone (PTH) secretion.
• The clinical manifestations and calcium balance are significantly influenced by vitamin D status and metabolism.

Purpose of the Study:

• To elucidate the roles of vitamin D and other factors in the pathogenesis of hypercalcemia in primary hyperparathyroidism.
• To explore the mechanisms underlying parathormone overproduction.

Main Methods:

• Review of existing literature on primary hyperparathyroidism, vitamin D metabolism, and calcium homeostasis.
• Analysis of factors influencing intestinal calcium absorption, bone resorption, and renal calcium reabsorption.

Main Results:

• Vitamin D sufficiency leads to intestinal hyperabsorption of calcium and renal stone risk.
• Vitamin D deficiency exacerbates bone resorption and osteoarticular symptoms.
• Unidentified factors also regulate renal calcium reabsorption, impacting hypercalcemia severity.
• PTH overproduction stems from reduced parathyroid cell sensitivity to calcium or increased parathyroid tissue mass.

Conclusions:

• Vitamin D status is a critical determinant of clinical presentation and severity in primary hyperparathyroidism.
• Both intestinal and osseous contributions to hypercalcemia are modulated by vitamin D.
• Further research is needed to identify factors influencing renal calcium handling in this condition.